Cittelly, Diana M <br/><br/>
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel.  [electronic resource] 

 -  Molecular cancer therapeutics  Dec 2012 
 - 2556-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-0463  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anoikis--drug effects<br/>Cell Adhesion--drug effects<br/>Cell Line, Tumor<br/>Disease Progression<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>MicroRNAs--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--pharmacology<br/>Transduction, Genetic--methods<br/>Transfection<br/>Tubulin--biosynthesis<br/>Tumor Burden<br/>Xenograft Model Antitumor Assays